Abstract
Deployment of Aedes aegypti mosquitoes carrying the endosymbiont bacterium Wolbachia has been identified as a promising strategy to reduce dengue, chikungunya, and Zika transmission. We investigated whether sampling larvae from ovitraps can provide reliable estimates on Wolbachia frequency during releases, as compared to the expensive adult-based BG-Sentinel. We conducted pilot releases in a semi-field system (SFS) divided into six cages of 21 m2, each with five ovitraps. Five treatments were chosen to represent different points of a hypothetical invasion curve: 10%, 25%, 50%, 75%, and 90% of Wolbachia frequency. Collected eggs were counted and hatched, and the individuals from a net sample of 27% of larvae per treatment were screened for Wolbachia presence by RT-qPCR. Ovitrap positioning had no effect on egg hatching rate. Treatment strongly affected the number of eggs collected and also the hatching rate, especially when Wolbachia was at a 10% frequency. A second observation was done during the release of Wolbachia in Rio under a population replacement approach when bacterium frequency was estimated using 30 BG-Sentinel traps and 45 ovitraps simultaneously. By individually screening 35% (N = 3904) of larvae collected by RT-qPCR, we were able to produce a similar invasion curve to the one observed when all adults were individually screened. If sampling is reduced to 20%, monitoring Wolbachia frequency with 45 ovitraps would be roughly half the cost of screening all adult mosquitoes captured by 30 BG-Sentinels. Our findings support the scale-up of Wolbachia releases, especially in areas with limited resources to afford massive trapping with BG-Sentinel traps.
Highlights
Arboviral infections such as dengue, Zika, and chikungunya are vector-borne diseases with high incidence over the tropics and subtropics, constituting one of the greatest public health challenges at the global level
Our findings support the scale-up of Wolbachia releases, especially in areas with limited resources to afford massive trapping with
One of the most promising tools to mitigate dengue, Zika, and chikungunya transmission relies on the release of Aedes aegypti mosquitoes transinfected with Wolbachia, an endosymbiont, maternally inherited that blocks arbovirus in mosquito vectors
Summary
Arboviral infections such as dengue, Zika, and chikungunya are vector-borne diseases with high incidence over the tropics and subtropics, constituting one of the greatest public health challenges at the global level. The mosquito Aedes aegypti (Diptera: Culicidae) is an important vector of the aforementioned pathogens. The development of new strategies to supplement traditional vector control methods is of utmost importance to manage mosquito-borne diseases [11,12]. One of these methodologies regards the mass release of Ae. aegypti carrying the maternally inherited endosymbiont Wolbachia, a bacterium able to block arbovirus and likely to reduce arbovirus transmission [13,14,15,16,17]. Wolbachia deployment has been currently undertaken in 14 countries and has become one of the most promising strategies to mitigate transmission
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
